USPTO serial 79365402
DNADX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 17, 2024
- Examiner
- WOLD, BARBARA NIELSEN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DNADX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Donna A. Tobin
Donna A. Tobin Royer Cooper Cohen Braunfeld LLP1120 Avenue of the Americas4th floorNew York, NY 10036Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations for scientific purposes, in the field of cancer; reagents for research purposes, in the field of cancer; reagents for medical research, in the field of cancer; diagnostic reagents for scientific or research use, in the field of cancer; reagents for scientific or research use in the field of cancer; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, in the field of cancer | ACTIVE | — |
| 005 | Diagnostic preparations for medical purposes, in the field of cancer; diagnostic reagents for medical use, in the field of cancer; diagnostic biomarker reagents for medical purposes, in the field of cancer; clinical medical reagents, in the field of cancer; medical diagnostic reagents for use in analysis of circulating tumor DNA extracted from blood samples, for use in the field of cancer; medical diagnostic reagents for use in diagnostic tests, in the field of cancer; biomarkers being copy number alterations and gene mutation for the diagnosis, prognosis and treatment of cancer; medical diagnostic reagents and assays for the diagnosis, prognosis and treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; compounds, namely, chemotherapy drugs, inmunotherapy agents, targeted drug therapies and hormonal therapies for treating cancer; pharmaceutical preparations for use in oncology; biological reagents for medical use, in the field of cancer; diagnostic reagent kits comprised of medical diagnostic reagents and assays for testing body fluids for medical use in the field of cancer. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by REVEAL GENOMICS S.L.
- Other trademarks owned by REVEAL GENOMICS S.L.
- Other trademarks owned by REVEAL GENOMICS S.L.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named DNADX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 15, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 24, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 24, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 17, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 17, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 17, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 31, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 14, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 14, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 2, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 2, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 1, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 12, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 11, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 11, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 28, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 7, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 7, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 7, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 12, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 12, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Feb 12, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 12, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 12, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 12, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 28, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Nov 7, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 7, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 4, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 3, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 3, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 21, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 17, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 16, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |